In spite of increasing reuse of disposable catheters, there are few scientific data on potential viral transmission and infection after reuse. To determine the theoretical risk of virus transmission during reuse of catheters an in vitro study was performed using an RNA virus (echovirus-11) and a DNA virus (adenovirus-2).
Introduction
Reuse of various medical devices, labelled for single-use only, has become common practice in many countries of the world, especially in developing countries, where the primary motive is cost containment coupled with the possibility of treating a larger population of patients. Many hospitals reprocess and reuse disposable medical devices such as haemodialyzers, intra-aortic balloons, syringes, biopsy forceps, and various types of catheters [1] [2] [3] [4] [5] [6] [7] . This practice raised increasing concern regarding the additional risks to the patients due to contamination by infectious [8] [9] [10] [11] , toxic [12] , or other possibly adverse substances [12, 13] , or as a result of biological incompatibility [13] or breakage [14, 15] of the medical devices. In spite of the increasing reuse of disposable catheters, there are little scientific data on the potential risk of viral transmission and infection. Viral and bacterial infection can be transmitted via intravascular devices [7] . Hepatitis B, HIV, and other blood and tissue-borne diseases such as spongiform encephalopathies (BSE) are of particular concern [16, 17] . However, it must be emphasized that, whatever the quality of reprocessing and sterilization, it is almost impossible to make sure that some blood and blood proteins do not remain entrapped in the lumen of the catheter and/or in some particular spaces of the deflated balloon. To determine the theoretical risk of virus transmission during reuse of catheters, an in vitro study was performed using an RNA virus (echovirus-11) and a DNA virus (adenovirus-2). After deliberate contamination of the catheters with these viruses, reprocessing and reuse of the cleaned catheters was simulated, after which the presence or absence of residual virus was determined by cell culture and by PCR.
Methods

Catheters
Twenty ethylene oxide sterilized 5F balloon catheters, of various balloon sizes and labelled for single-use only, were used in this study. The manufacturing information of these catheters is summarized in Table 1 . The inflated balloon surface was estimated to be 2 rl (r=radius; l=length) assuming cylindrical geometry.
Viruses
The viruses used in this study, echovirus type 11 [18] and adenovirus type 2 [19] , were chosen since they represent both the RNA viruses (the echovirus) and the DNA viruses (the adenovirus). In addition they can both be cultured quite easily to relatively high infectious titres, whereas they are relatively stable under unusual physical conditions [20] . In addition both viruses are associated with a large variety of clinical symptoms in humans, including neurological symptoms, cardiovascular problems, respiratory symptoms, gastrointestinal symptoms, and various skin problems. Laboratory strains of both viruses were grown in locally produced human embryonic lung fibroblasts (HELF), using minimum essential medium with Hank's salts (HMEM), supplemented with non-essential amino acids and 3% fetal calf serum (FCS) . After the cell cultures had reached extensive cytopathic effect the culture supernatants were decanted, cleared by low-speed centrifugation (7 min, 440 g), and stored at 70 C in 2 ml aliquots until use. The infectious titres of the stored virus preparations were determined by inoculating 10-fold dilutions of each virus on HELF in microtitre plates in six-fold, and examined for the presence of a cytopathic effect after 6 days. The titres were calculated using the method of Reed and Muench [21] and expressed as 50% tissue-cultureinfectious-dose (TCID 50 ) per ml. The echo-11 virus preparation contained 6 10 8 TCID 50 /ml, which was diluted with culture medium to 3 10 6 TCID 50 /ml before use. The adenovirus-2 preparation contained 6 10 5 TCID 50 /ml, which was used undiluted.
Contamination of the catheters
Each balloon catheter was locked up in a polypropylene tubing system (length 85 cm, internal diameter 5 mm), which was mounted vertically and closed at the distal (lower) end with a clamp. Ten catheters (nos 1-10) were exposed each to 10 ml of the working dilution of echovirus-11 in culture medium. A second series of 10 catheters (nos [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] were each exposed to 10 ml of the adenovirus-2 suspension. The virus suspensions were carefully injected into the lumen of the catheters from a non-pyrogenic syringe attached to the hub of the catheter. The injected volume was enough to assure that the lumen as well as the exterior of the catheter was in contact with the virus suspension, the latter being immersed bottom-up via the lumen. The total exposure time was 1 h at 37 C. Both at the beginning and the end of the exposure period the balloons were inflated and 
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deflated with air for 1 min. All handling of the catheters -including all experimental steps described below -were performed using gloves, which were frequently changed, in order to prevent crosscontamination between different catheters and different test samples.
Cleaning, sterilization, and simulation of reuse of the catheters
After 1 h, all combined catheter/tubing systems were returned to room temperature (22 2 C) and the virus suspensions removed from the catheter and tube by opening the bottom-clamp at the polypropylene tube. Aliquots of each suspension (sample A) were used as positive controls during later analysis. Each catheter/ tubing combination was subsequently air-dried using a large syringe with a sterile pyrogen-free disposable filter, and kept dry for another 4 h before the cleaning procedure was started. To prevent cross-contamination, the catheters were left in place during all subsequent cleaning procedures. After the 4 h drying period all catheter/tubing systems were flushed with 25 ml of sterile non-pyrogenic water (NPBI, Emmer-Compascuum, The Netherlands) and soaked for 15 min in 2% LIQUI-NOX (Alconox Inc, New York, U.S.A.), a detergent which is often used for critical cleaning in hospitals, laboratories and industry. After removal of the detergent all catheter/tubing systems were flushed again with 25 ml of sterile non-pyrogenic water (sample B). The catheter/tubing systems were then air dried and sterilized during 30 min with CIDEX (Johnson & Johnson Medical, Amersfoort, The Netherlands), a sterilant-desinfectant containing 2·2% glutaraldehyde. After removal of the sterilant-desinfectant the systems were flushed again with 25 ml of non-pyrogenic water (sample C) after which the cleaning was completed by air-drying. Reuse was simulated by exposing the catheters to 10 ml of virus-free cell-culture medium at 37 C. During an exposure time of 1 h the balloons were inflated and deflated for 1 min at the beginning and the end of the procedure, after which medium was removed (sample D). Subsequently the catheter-tip, including the balloon, was cut off from the catheter body and immersed in a tube containing virus-free culture medium. After sonification of the contents of the tube at high frequency, using a sonification water bath, sample E was taken. Immediately after collection, each of the aqueous samples B and C (25 ml each) was supplemented with 2·5 ml of 10 concentrated HMEM. Subsequently, aliquots of all samples A-E were assayed by cell culture, and the remainder stored in 2 ml portions at 70 C until PCR testing.
Virus detection by cell culture techniques
All samples were tested on HELF cell cultures for the presence of either enterovirus or adenovirus, using both conventional tube cell cultures and shell vial cultures with cover slips, all grown in HMEM, non-essential amino acids and 10%FCS as described previously [22, 23] . The tube cell cultures were used for testing of all 100 collected A-E samples in duplicate, whereas the additional shell vial cultures were used for testing all B-E samples. All cultures were inoculated with 0·2 ml portions of the test samples, after which the inoculation on the shell vial cultures was further enhanced by centrifugation at 700 g for 45 min. The monolayers in tube cell cultures were microscopically examined for a virus specific cytopathic effect for up to 7 days. Monolayers showing a cytopathic effect were considered to be positive for either enterovirus or adenovirus. The shell vial cultures were all stopped 1 day after inoculation by replacing the medium with 1 ml of acetone and leaving the culture at 20 C for 10 min, after which the cover slips with fixed monolayers were removed and stained with monoclonal antibodies. The cover slips from cultures inoculated with samples from catheters 1-10 were all incubated with a 1/100 dilution of a monoclonal antibody specific for enteroviruses (DAKO A/S Denmark, clone 5-D8/1) for 30 min at 37 C, rinsed with phosphate buffered saline, and stained for 30 min at 37 C with fluorescein isothiocyanate (FITC)-labelled rabbit antimouse immunoglobulin (DAKO A/S, Denmark) at a dilution of 1/40. Cover slips from cultures inoculated with samples from catheters 11-20 were all stained for 30 min at 37 C with a 1/4 dilution of FITC-labelled monoclonal antibody to adenovirus (Imagen, DAKO diagnostics Ltd, Ely, U.K.). All stained cover slips were examined for the presence of virus specific immunofluorescence.
Enterovirus PCR
All samples A-E from catheters 1-10 were tested for the presence of enterovirus RNA by reverse transcription polymerase chain reaction (RT-PCR) using the Amplicor enterovirus PCR assay (Roche Diagnostics, Branchburg, NJ, U.S.A.), which are known to react with most enterovirus types, including enterovirus type-11 [24] . From 200 l aliquots of each sample, RNA was extracted using guanidinium thiocyanate lysis and fractionation on Celite, as described by Boom et al. [25] . Twenty microlitres of extract, corresponding to 40 l of the original sample, were mixed with 30 l of the Amplicor enterovirus specimen diluent and added to 50 l of the Amplicor enterovirus master mix. In the Amplicor enterovirus PCR assay, the reverse transcription and amplification steps are combined through the use of the thermo stable enzyme rTth (recombinant Thermus thermophilus) polymerase. Biotinylated enterovirus-specific primers are located at the 5 noncoding region of the enterovirus genome. Detection is performed colorimetrically on a micro well plate with an immobilized oligonucleotide probe specific for enterovirus. The detection limit is claimed to be one TCID 50 unit per amplification reaction. Using the Amplicor enterovirus PCR assay method we recently participated successfully in the quality assessment programme of the European Union Concerted Action on Quality Control of Nucleic Acid Amplification in Diagnostic Virology (EU-QCCA).
Adenovirus PCR
All samples D and E from the adenovirus contaminated catheters 11-20 were tested for the presence of adenovirus DNA by semi-nested PCR specific for universal sequences of the hexon gene [26] . For the first 35 amplification reactions, the forward primer U1 (5 cat ymg vgg sgt sct kga3 ) and the reverse primer U3 (5 crt cyt tbc kga agt tcc a3 ) were used, generating a 1576 bp fragment. The second series of 35 amplification reactions was performed with primer U3 and the forward primer U2 (5 aay acm tay gms tac atg aac3 ), generating a 270 bp fragment. Preliminary experiments showed that these primer sets amplify at least 14 different types of adenoviruses, including adenovirus type-2. Before testing, the samples were first cleared by centrifugation for 5 min at 4000 g and then treated with proteinase K for 1 h at 56 C. After subsequent inactivation of the enzyme by heating the tubes for 5 min at 100 C, aliquots of 10 l -corresponding to 10 l of the original sample -were used in 50 l amplification reactions. The second series of amplifications was performed on 1 l of the initial amplification product. In both series of amplification reactions, 1 unit Taq polymerase (Amplitaq, Perkin Elmer), 1·5 m MgCl 2 and 25 pmol of each primer was used in cycles of 30 s at 94 C (denaturation step); 1 min at 50 C (annealing step); 1 min at 72 C (elongation step).
Results
Each catheter was tested for the presence of virus at four different stages: just after contamination (sample A), after washing (sample B), after sterilization (sample C) and after simulation of reuse (samples D and E). The overall results of enterovirus detection in the samples from catheters 1-10 and of adenovirus detection in the samples from catheters 11-20 are summarized in Tables  2 and 3 , respectively. Since all tests on A-samples were positive, each catheter had successfully been contaminated. The results with the B-samples from the enterovirus-contaminated catheters 1-10 showed that the washing step with detergent was not very effective in removing enterovirus: in 90%, 100% and 100% of the samples the virus was still detectable with tube cell culture, shell vial culture and PCR, respectively. After the sterilization step, infectious enterovirus was detectable in only one of the C-samples, whereas two other samples contained detectable enterovirus RNA. The same catheter (no. 1) was also the only enterovirus culture positive catheter after simulated reuse (sample D). In contrast, no less than six (60%) of the D-samples (from catheters 1, 3, 4, 5, 7 and 10) gave positive enterovirus PCR results. After sonification of the catheter tips no infectious virus could be recovered, but enterovirus RNA was detected in two of the E-samples from catheters 1 and 5. The results with the adenoviruscontaminated catheters [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] showed that infectious adenovirus could still be recovered from the B-samples from nine (90%) catheters immediately after the washing step, five times using tube cell culture and eight times using shell vial culture. After sterilization, no adenovirus could be detected in the C-samples by any of the culture methods. After the simulation of reuse, no infectious adenovirus was detected in either of the D and E samples, but adenovirus DNA was still detectable in one (10%) of the D samples and three (30%) of the E samples.
Discussion
This study clearly shows that complete removal of virus from contaminated catheters is hardly possible. After reuse of the extensively cleaned and sterilized catheters, samples from one of the catheters still contained infectious enterovirus, but no infectious adenovirus was found. In contrast, samples from six and three catheters were still positive by enterovirus RNA reverse transcription-PCR and adenovirus DNA PCR, respectively. Possibly, adenovirus might be more effectively removed than enterovirus. However, one has to consider that the input concentration of adenovirus was only one fifth of the input concentration of enterovirus. Moreover, each enterovirus PCR was performed on 40 l of the test sample, whereas our adenovirus PCR protocol could handle no more than 10 l. Testing larger volumes in PCR assays may lead to false-negative results due to inhibition of the PCR enzymes. By using internal controls we made sure that none of the negative PCR results in the present study was caused by inhibition (data not shown). For both viruses the PCR assays clearly gave more positive results than the culture methods, notwithstanding that culture was performed on 200 l aliquots. The most obvious explanation is the far greater sensitivity of PCR, so culture-negative PCR-positive samples may still contain traces of infectious virus. Alternatively one might argue that PCR may also detect noninfectious enterovirus RNA or adenovirus DNA, which implies that culture-negative PCR-positive samples may not contain any infectious virus. Although we cannot rule out that the latter possibility predominates, the former possibility probably plays a role as well. This was underlined by the observation that one of the enterovirus-contaminated catheters was still culture positive after reuse.
In the present study, cleaning and sterilization of the catheters was performed according to commonly used procedures [27] . According to Canadian guidelines, cleaning of endoscopes by soaking in 2% glutaraldehyde for Table 2 Table 2 .
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12-20 min is considered to be highly effective [28] . Therefore one might have expected that soaking in 2·2% glutaraldehyde for 30 min, as was practiced in our study, would have inactivated all viruses. However, since we were still able to detect virus after simulated reuse of the completely reprocessed catheters, the standard cleaning and sterilization procedures appeared to be clearly inadequate in our experiment. The viruses might have been protected to a certain extent, for instance as a result of entrapment in the lumen of the catheter and/or between foldings of the deflated balloons. However, there was no clear-cut relationship between balloon size, balloon surface, and positivity. In addition, no relationship between the detection of virus and catheter/balloon materials was observed. A possible additional factor in protecting the viruses may have been the presence of protein, e.g. virus protein plus FCS from the culture medium -which is relatively low as compared with total blood proteinduring the contamination step. During air-drying of the catheters a thin protein film may become firmly attached to the surface of lumen or balloon, resulting in poor penetration of the cleaning and sterilization agents [28] . Although data to support this idea are scarce, Alfa et al. [29] showed that when long narrow lumens (tubing of 125 cm long with an internal diameter of 3 mm) were inoculated with bacteria, microbial killing by ethylene oxide (EtO) -the standard procedure -is detrimentally affected by the presence of 10% serum and 0·65% salt in the bacterial suspension. It was hypothesized that the combination of serum and salt caused a poor penetration of the gas into the narrow lumen and, as a result, protection of the bacteria.
Since the simulated reuse of the catheter in our study consists of exposing them to aqueous medium for 60 min, it seems conceivable that the thin protein layer is gradually softened, leading to release of virus particles. Similarly, one can imagine that when catheters are used in medical practice, blood proteins, lipids, carbohydrates, cells and cell debris may easily attach to the catheter lumen surface, providing a substrate or mantle for bacterial and viral survival during disinfection and sterilization procedures, and thereby creating the potential for virus or bacterial transmission during reuse. Ng et al. [12] showed that various blood components such as fibrin and blood cells still adhered to the dialyser membrane after reprocessing. Their study also demonstrated that the adhered blood components could be detached by simulated haemodialysis and then gain access into the circulation.
In 1993 Spach et al. [10] reviewed several cases ofmainly bacterial -infections transmitted by gastrointestinal endoscopy and by bronchoscopy, including one case of transmission of hepatitis B virus, a DNA virus, by endoscopies [11] . More recently Bronowicki et al. [9] reported the transmission of hepatitis-C virus, an RNA virus, from one patient to two other patients as a result of colonoscopy. In this study the patientto-patient transmission was proven by sequencing the genomes of the HCV viruses obtained from each patient. Brink et al. [8] used an animal model to establish the risk of transmitting infectious virus by subcutaneous jet injection. In this study lactic dehydrogenase virus was transmitted from chronically infected mice to noninfected control mice in 16 out of 49 cases (32·6%). It was concluded that less than 10 7 ml of serum of the acutely infected animal could contain enough infective particles to transmit the infection.
Obviously, devices with long narrow lumens such as catheters and endoscopes present serious problems for the complete removal of bloody materials and verification of cleanliness. During reuse of these devices residual organic debris or blood proteins may enter the blood circulation, possibly together with infectious agents. Besides the increased risk of infection of the patient, the contaminating substances may also induce or modify the immune system [3, 12, 13] , but that has not yet been investigated sufficiently.
The sterilization methods routinely used in hospitals, such as EtO treatment, may also not inactivate all prions, the causative agents of Creutzfeldt-Jakob disease (CJD). Although transmission of CJD by reuse of medical devices, or via blood transfusion, has not been described so far, such possible routes of transmission of CJD have still not been ruled out, among others, since the latency period of CDJ may be up to 20 years [16, 17] . In July 1996 , in response to concerns regarding the possible transmission of CJD, the province of Quebec (Canada) banned the practice of reuse of percutaneous transluminal coronary angioplasty catheters. Many institutions, however, still routinely resterilize and reuse catheters to reduce the costs.
So far the published data on reprocessing and reuse of catheters and other disposables are limited to the evaluation of clinical end-points, such as hypotension, fever and chills, pyrogenic reactions and other catheterrelated complications [2, 7, 30] . Other studies focused on the mechanical performances of medical devices or on sterilization conditions [3, 14, 15, 31] , but protocols for validation of cleaning and sterilization, and estimations of the potential risks of virus transmission are still lacking.
The present in vitro study clearly demonstrates that, even after rigorous cleaning and sterilization, virus was still present in some catheters. Therefore reuse of diagnostic and interventional cardiovascular and endovascular catheters is dangerous and should not be carried out.
